Literature DB >> 7904669

Reduced transfer of tetanus antibodies with placental malaria.

M E Brair1, B J Brabin, P Milligan, S Maxwell, C A Hart.   

Abstract

Placental malaria may limit antibody transfer to the fetus. We compared concentrations of tetanus antibody in paired maternal-cord sera from 224 women living in a malarious area of Papua New Guinea. With heavy placental infection (> 35 parasites per 200 white cells) the average cold tetanus antibody corresponding to a maternal level of 1 IU/mL was 0.18 (95% CI 0.12-0.26); corresponding figures after light (< 35 parasites per 200 white cells) or no infection were 0.23 (0.14-0.34) and 0.82 (0.57-1.21), respectively. About 10% of babies born to mothers with a placenta heavily infected with Plasmodium falciparum may fail to acquire protective levels of tetanus antibody despite adequate maternal antibody.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7904669     DOI: 10.1016/s0140-6736(94)90991-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

Review 1.  Tetanus.

Authors:  J J Farrar; L M Yen; T Cook; N Fairweather; N Binh; J Parry; C M Parry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

2.  Parasitic Infections in Pregnancy Decrease Placental Transfer of Antipneumococcus Antibodies.

Authors:  Noah D McKittrick; David M Vu; Indu Malhotra; Charles H King; Francis Mutuku; A Desiree LaBeaud
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

3.  Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy.

Authors:  T J O'Dempsey; T McArdle; S J Ceesay; O Secka; E Demba; W A Banya; N Francis; B M Greenwood
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

4.  Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.

Authors:  Sam Salman; Susan Griffin; Kay Kose; Nolene Pitus; Josephine Winmai; Brioni Moore; Peter Siba; Kenneth F Ilett; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

Review 5.  Tetanus toxoid immunization to reduce mortality from neonatal tetanus.

Authors:  Hannah Blencowe; Joy Lawn; Jos Vandelaer; Martha Roper; Simon Cousens
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

6.  Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.

Authors:  David R Martinez; Youyi Fong; Shuk Hang Li; Fang Yang; Madeleine F Jennewein; Joshua A Weiner; Erin A Harrell; Jesse F Mangold; Ria Goswami; George R Seage; Galit Alter; Margaret E Ackerman; Xinxia Peng; Genevieve G Fouda; Sallie R Permar
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

7.  Why Should We Advocate Maternal Immunization?

Authors:  Jim Boonyaratanakornkit; Helen Y Chu
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

Review 8.  Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems.

Authors:  V Dietz; A Galazka; F van Loon; S Cochi
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

9.  Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy.

Authors:  Sidney Ogolla; Ibrahim I Daud; Amolo S Asito; Odada P Sumba; Collins Ouma; John Vulule; Jaap M Middeldorp; Arlene E Dent; Saurabh Mehta; Rosemary Rochford
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

10.  Placental antibody transfer: influence of maternal HIV infection and placental malaria.

Authors:  M I de Moraes-Pinto; F Verhoeff; L Chimsuku; P J Milligan; L Wesumperuma; R L Broadhead; B J Brabin; P M Johnson; C A Hart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.